Royal Bank of Canada’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14K | Buy |
1,513
+127
| +9% | +$1.18K | ﹤0.01% | 5997 |
|
|
2025
Q1 | $10K | Sell |
1,386
-328
| -19% | -$2.37K | ﹤0.01% | 5769 |
|
|
2024
Q4 | $18K | Sell |
1,714
-31,822
| -95% | -$334K | ﹤0.01% | 5649 |
|
|
2024
Q3 | $490K | Buy |
33,536
+782
| +2% | +$11.4K | ﹤0.01% | 3707 |
|
|
2024
Q2 | $397K | Buy |
32,754
+4,835
| +17% | +$58.6K | ﹤0.01% | 3824 |
|
|
2024
Q1 | $689K | Sell |
27,919
-1,565
| -5% | -$38.6K | ﹤0.01% | 3361 |
|
|
2023
Q4 | $315K | Buy |
29,484
+928
| +3% | +$9.92K | ﹤0.01% | 4172 |
|
|
2023
Q3 | $239K | Sell |
28,556
-241
| -0.8% | -$2.02K | ﹤0.01% | 4163 |
|
|
2023
Q2 | $228K | Buy |
28,797
+858
| +3% | +$6.79K | ﹤0.01% | 4205 |
|
|
2023
Q1 | $139K | Buy |
27,939
+62
| +0.2% | +$308 | ﹤0.01% | 4530 |
|
|
2022
Q4 | $61K | Sell |
27,877
-618
| -2% | -$1.35K | ﹤0.01% | 5299 |
|
|
2022
Q3 | $126K | Buy |
28,495
+116
| +0.4% | +$513 | ﹤0.01% | 4673 |
|
|
2022
Q2 | $91K | Sell |
28,379
-154
| -0.5% | -$494 | ﹤0.01% | 4940 |
|
|
2022
Q1 | $162K | Buy |
28,533
+330
| +1% | +$1.87K | ﹤0.01% | 4798 |
|
|
2021
Q4 | $366K | Hold |
28,203
| – | – | ﹤0.01% | 4250 |
|
|
2021
Q3 | $686K | Buy |
28,203
+76
| +0.3% | +$1.85K | ﹤0.01% | 3607 |
|
|
2021
Q2 | $487K | Buy |
28,127
+27,791
| +8,271% | +$481K | ﹤0.01% | 3870 |
|
|
2021
Q1 | $11K | Buy |
336
+147
| +78% | +$4.81K | ﹤0.01% | 6262 |
|
|
2020
Q4 | $2K | Buy |
+189
| New | +$2K | ﹤0.01% | 6300 |
|